Grasim vs Bajajfinsv Q4 FY24

Grasim reported its highest-ever consolidated revenue of INR 1,30,978 crore and EBITDA of INR 20,837 crore for FY24, driven by record volumes in cement, cellulosic fiber, and caustic soda. The paints business (Birla Opus) commenced production at three plants and is on track to onboard 50,000 dealers in FY25, targeting high single-digit market share by year-end. The B2B e-commerce platform crossed INR 1,000 crore revenue in its first year. However, the chemicals segment faced headwinds from weak chlorine derivatives demand, and a one-time impairment of INR 497 crore was taken on the AV Terrace Bay joint venture. Management guided for standalone CapEx of ~INR 4,500 crore in FY25, largely for paints. Key risk: aggressive competition in paints could pressure pricing and market share gains.

Guidance read

Paints: High single-digit market share by FY25 exit: Birla Opus aims to exit FY25 with high single-digit market share, supported by dealer onboarding and product quality. Paints: INR 10,000 crore revenue by FY28: Target to achieve INR 10,000 crore revenue in the third year of full operations, with profitability at that point. B2B E-commerce: $1 billion revenue in 3 years: Birla Pivot aspires to reach $1 billion revenue in the next three years. Standalone CapEx of ~INR 4,500 crore in FY25: Majority allocated to paints business; part of the INR 10,000 crore paints CapEx plan.

Risk read

Key risks include Aggressive competition in paints — Incumbents are actively defending market share with increased dealer visits and promotions, which could slow Birla Opus's market share gains.; Weakness in chlorine derivatives — Chlorine derivatives demand remains subdued due to agrochemical weakness, impacting chemical segment profitability.; Global oversupply in chemicals — Surplus capacity in China and weak global demand keep chemical prices range-bound, limiting margin improvement.; Paints capacity utilization risk — Aggressive capacity build-out may lead to lower utilization if demand ramp-up is slower than expected, impacting profitability timeline..

Promise ledger

Of 2 tracked promises, management 0 met, 0 close, 2 missed.

Bajaj Finserv reported a strong Q4 FY24 with consolidated total income up 36% YoY to INR 32,042 crore and PAT up 20% to INR 2,119 crore. The general insurance arm (BAGIC) grew gross written premium 32% YoY, significantly outpacing industry growth of 10.9%, though the combined ratio weakened to 101.6% from 97.3% due to higher claims. Life insurance (BALIC) delivered individual rated premium growth of 17% on a high base, with NBV up 16% to INR 480 crore. Bajaj Finance continued its robust performance with 25% revenue growth and 21% PAT growth. Management highlighted market share gains in both insurance businesses and expressed optimism about sustained growth driven by favorable macros and regulatory tailwinds. Key risks include competitive intensity in motor insurance, potential regulatory changes on surrender charges, and the cyclical nature of tender-driven government health and crop businesses.

Guidance read

BAGIC to maintain above-market growth with balanced profitability: Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given. BALIC to grow faster than industry with improving margins: Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided. Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25: Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.

Risk read

Key risks include Motor TP pricing uncertainty — No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.; Regulatory risk on surrender charges for life insurance — Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.; Dependence on tender-driven government health and crop business — Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.; Persistency pressure in life insurance from older cohorts — 37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving..

Promise ledger

Of 3 tracked promises, management 0 met, 0 close, 3 missed.